Indapamide
Inquiry
| Post Date: | Feb 20,2026 |
| Expiry Date: | Aug 19,2026 |
| Detailed Description: | Cas No. :26807-65-8 |
| CAS Registry Number: | 26807-65-8 |
| Synonyms: | ;N-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline;N-[4-chloro-3-sulfamoyl-benzamidol]-2-methylindoline;1-(4-chloro-3-sulfamoylbenzamido)-2-methylindoline;3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)-benzamid;3-(aminosulfonyl)-4-chloro-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide;4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoyl-benzamid;4-chloro-n-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide;bajaten;damide;fludex;indaflex;indamol;ipamix;lozol;natrilix;noranat;s1520;se-1520;tandix;INDAPAMID;Indapamidum;4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide;indaparnide; |
| Molecular Formula: | C16H16ClN3O3S |
| Molecular Weight: | 365.8345 |
| Molecular Structure: | 
|
| Company: | Tianjin Minxiang Biology Pharmaceutical Technology Co.,Ltd. [ China ] |
| Contact: | liu |
| Tel: | +86-22-28574646 28574747 28571 |
| Fax: | +86-22-28573300 |
| Email: | tjmx@mxpharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
-
- n-tricyclo[3.3.1.13,7]dec-...
- 1-Adamantanamine hydrochlo...
- Timolol Maleate
- N-Hydroxysuccinimide
- N-(hydroxy)phthalimde
- Tazobactam sodium
- Tazobactam
- 2-Adamantanone
- VerapamilHydrochloride
- Quetiapine fumarate
- Nimodipime
- 2-Adamantanol
- Norfloxacin
- Clopidogrel
- EmtricItabine
- S-3-tert-Butylamino-1,2-pr...
- 3-Chloro-4-morpholino-1,2,...
- 3,4-dimethoxyphenyl-aceton...
- Trans-3,5,4'-trihydroxysti...
- Atenolol
- Desonide
- Budesibude
- Potassium bromide
- Sodium bromide
- Fosfomycin Phenylethylamin...
